Molecular Assemblies announced it raised $2.3 million in seed funding. The company aims to revolutionize the field of synthetic DNA production with their enzymatic DNA synthesis technology.
“Molecular Assemblies says new methods of writing genetic code to customer specifications are needed to realize the promise of next-generation genomics, from personalized DNA-based therapies and diagnostics to industrial applications of synthetic biology.” – Bruce V. Bigelow, editor of Xconomy San Diego
